Japan’s Meiji Holdings has acquired Bangalore-based pharmaceutical firm Medreich for $290 million (Rs. 1,720 crore)..Amarchand Mangaldas acted for Medreich with a team led by Mumbai Corporate Partner Ashish Jejurkar, and Mumbai Tax Partner SR Patnaik advised on tax related issues..Khaitan & Co acted as Indian legal counsel for Meiji while Anderson Mori acted as Japanese Counsel with Partners Yuichiro Nukada and Ryo Okochi..The Khaitan team was led by Corporate Partner Bhavik Narsana. He was assisted by Banking & Finance Partner Kumar Saurabh Singh along with Intellectual Property Partner Adheesh Nargolkar, Real Estate Partner Abhishek Sharma and Regulatory Partner Sharad Vaid. Partner Avaantika Kakkar advised on the competition law aspect..The transaction also provides an exit to Singapore government’s investment arm Temasek Holdings, which had invested Rs.109 crore in Medreich for a 25% stake in 2005, reports Mint.
Japan’s Meiji Holdings has acquired Bangalore-based pharmaceutical firm Medreich for $290 million (Rs. 1,720 crore)..Amarchand Mangaldas acted for Medreich with a team led by Mumbai Corporate Partner Ashish Jejurkar, and Mumbai Tax Partner SR Patnaik advised on tax related issues..Khaitan & Co acted as Indian legal counsel for Meiji while Anderson Mori acted as Japanese Counsel with Partners Yuichiro Nukada and Ryo Okochi..The Khaitan team was led by Corporate Partner Bhavik Narsana. He was assisted by Banking & Finance Partner Kumar Saurabh Singh along with Intellectual Property Partner Adheesh Nargolkar, Real Estate Partner Abhishek Sharma and Regulatory Partner Sharad Vaid. Partner Avaantika Kakkar advised on the competition law aspect..The transaction also provides an exit to Singapore government’s investment arm Temasek Holdings, which had invested Rs.109 crore in Medreich for a 25% stake in 2005, reports Mint.
